121 related articles for article (PubMed ID: 2096160)
1. Growth hormone therapy in a poorly growing child with hypophosphatemic rickets.
Lanes R; Harrison HE
J Endocrinol Invest; 1990 Nov; 13(10):833-7. PubMed ID: 2096160
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy in hypophosphatemic rickets.
Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and hypophosphatemic rickets.
Wilson DM
J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():993-8. PubMed ID: 11086653
[TBL] [Abstract][Full Text] [Related]
4. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
5. [Growth hormone treatment of familial hypophosphatemic rickets].
Saggese G; Baroncelli GI; Barsanti S
Arch Pediatr; 1998; 5 Suppl 4():360S-363S. PubMed ID: 9853084
[TBL] [Abstract][Full Text] [Related]
6. A single case of hypophosphatemic rickets with hypercalciuria.
Nishiyama S; Inoue F; Matsuda I
J Pediatr Gastroenterol Nutr; 1986; 5(5):826-9. PubMed ID: 3761117
[TBL] [Abstract][Full Text] [Related]
7. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
[TBL] [Abstract][Full Text] [Related]
8. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G
J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622
[TBL] [Abstract][Full Text] [Related]
9. Effects of therapy in X-linked hypophosphatemic rickets.
Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
[TBL] [Abstract][Full Text] [Related]
10. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD
J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
[TBL] [Abstract][Full Text] [Related]
11. Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets.
Makitie O; Toiviainen-Salo S; Marttinen E; Kaitila I; Sochett E; Sipila I
Horm Res; 2008; 69(4):212-20. PubMed ID: 18204268
[TBL] [Abstract][Full Text] [Related]
12. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
Živičnjak M; Schnabel D; Staude H; Even G; Marx M; Beetz R; Holder M; Billing H; Fischer DC; Rabl W; Schumacher M; Hiort O; Haffner D;
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957
[TBL] [Abstract][Full Text] [Related]
13. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
Chan JC; Lovinger RD; Mamunes P
Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphatemic rickets: effect of 1 alpha, 25-dihydroxyvitamin D3 on growth and mineral metabolism.
Chan JC; Bartter FC
Pediatrics; 1979 Oct; 64(4):488-95. PubMed ID: 492815
[TBL] [Abstract][Full Text] [Related]
15. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
Alon U; Chan JC
J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous Growth and Effect of Early Therapy with Calcitriol and Phosphate in X-linked Hypophosphatemic Rickets.
Cagnoli M; Richter R; Böhm P; Knye K; Empting S; Mohnike K
Pediatr Endocrinol Rev; 2017 Nov; 15(Suppl 1):119-122. PubMed ID: 29292875
[TBL] [Abstract][Full Text] [Related]
17. A trial of growth hormone therapy in well-controlled hypophosphataemic rickets.
Cameron FJ; Sochett EB; Daneman A; Kooh SW
Clin Endocrinol (Oxf); 1999 May; 50(5):577-82. PubMed ID: 10468922
[TBL] [Abstract][Full Text] [Related]
18. Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia.
Friedman NE; Lobaugh B; Drezner MK
J Clin Endocrinol Metab; 1993 Apr; 76(4):839-44. PubMed ID: 8473393
[TBL] [Abstract][Full Text] [Related]
19. Iron Supplementation Associated With Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets.
Kapelari K; Köhle J; Kotzot D; Högler W
J Clin Endocrinol Metab; 2015 Sep; 100(9):3388-92. PubMed ID: 26186302
[TBL] [Abstract][Full Text] [Related]
20. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
